Cardiac allograft rejection as a complication of PD-1 checkpoint blockade for cancer immunotherapy: a case report
Taofeek K. Owonikoko(UPMC Hillman Cancer Center), Suresh S. Ramalingam(Emory University), Vivek Nautiyal(Emory University), Gabriel Sica(Emory University), Monica Chatwal(Emory University), Wendy Book(Emory University), Rama Akondy(Emory University), Mukesh Kumar(Emory University), Shu Yang(Central South University), Anurag Sahu(Emory University), Alice O. Kamphorst(Icahn School of Medicine at Mount Sinai), Rathi N. Pillai(Emory University), Rafi Ahmed(Emory University)
Cited by 59
Related Papers
Osimertinib or Platinum–Pemetrexed in <i>EGFR</i> T790M–Positive Lung Cancer
|New England Journal of Medicine|2016|3.3k
Lineage relationship and protective immunity of memory CD8 T cell subsets
|Nature Immunology|2003|1.9k
Immunology of COVID-19: Current State of the Science
|Immunity|2020|1.8k
Sotorasib for Lung Cancers with <i>KRAS</i> p.G12C Mutation
|New England Journal of Medicine|2021|1.8k